Artificial Light at Night (ALAN), an alarm to ovarian physiology: A study of possible chronodisruption on zebrafish (Danio rerio)
SCIENCE OF THE TOTAL ENVIRONMENT
Authors: Khan, Zeeshan Ahmad; Labala, Rajendra Kumar; Yumnamcha, Thangal; Devi, Sijagurumayum Dharmajyoti; Mondal, Gopinath; Devi, Haobijam Sanjita; Rajiv, Chongtham; Bharali, Rupjyoti; Chattoraj, Asamanja
Abstract
The ALAN is drawing the attention of researchers and environmentalists for its ever-increasing evidence on its capacity of "desynchronization" of organismal physiology. Photoperiod and circadian cycles are critical parameters to influence the biology of reproduction in several animals, including fish. The present study is the first proof of the development of an ovarian tumour with the effect of light in zebrafish (Danio rerio), an excellent model for circadian-related studies. Results of three experimental conditions, continuous light for one week, LLW, one month, LLM, and for one year, LLY revealed a dear desynchronization of clock associated genes (Clock1a, Bmal1a, Per2, and Cry2a). Interestingly, loss of rhythmicity and low concentration of melatonin found in these conditions in whole brain, retina, ovary, and serum through ELISA. RNA-Seq data of ovarian samples revealed the upregulation of Mid2, Tfg, Irak1, Pim2, Tradd, Tmem101, Nfkbib genes and ultimately increase the expression of NF-kappa B, a cellular transformer for tumourigenesis, confirmed by the western blot. The appearance of TNF alpha, inflammatory cytokines and activator of NF-kappa B also increased. Histology approved the formation of thecoma and granulosa cell tumour in the one year exposed ovarian sample. The whole transcriptome data analysis revealed 1791 significantly upregulated genes in an ovarian tumour. Among these genes, DAVID functional annotation tool identified 438 genes, directly linked to other physiological disorders. This study evidenced of an ovarian tumour induced by ALAN in zebrafish. (C) 2018 Elsevier B.V. All rights reserved.
Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-kappa B/YY1 axis
MOLECULAR ONCOLOGY
Authors: Liu, Jia; Zhan, Yang; Wang, Jiefu; Wang, Junfeng; Guo, Jiansheng; Kong, Dalu
Abstract
Metastasis accounts for poor prognosis of cancers and related deaths. Accumulating evidence has shown that long noncoding RNAs (lncRNAs) play critical roles in several types of cancer. However, which lncRNAs contribute to metastasis of colon cancer is still largely unknown. In this study, we found that lncRNA LINC01578 was correlated with metastasis and poor prognosis of colon cancer. LINC01578 was upregulated in colon cancer, associated with metastasis, advanced clinical stages, poor overall survival, disease-specific survival, and disease-free survival. Gain-of-function and loss-of-function assays revealed that LINC01578 enhanced colon cancer cell viability and mobility in vitro and colon cancer liver metastasis in vivo. Mechanistically, nuclear factor kappa B (NF-kappa B) and Yin Yang 1 (YY1) directly bound to the LINC01578 promoter, enhanced its activity, and activated LINC01578 expression. LINC01578 was shown to be a chromatin-bound lncRNA, which directly bound NFKBIB promoter. Furthermore, LINC01578 interacted with and recruited EZH2 to NFKBIB promoter and further repressed NFKBIB expression, thereby activating NF-kappa B signaling. Through activation of NF-kappa B, LINC01578 further upregulated YY1 expression. Through activation of the NF-kappa B/YY1 axis, LINC01578 in turn enhanced its own promoter activity, suggesting that LINC01578 and NF-kappa B/YY1 formed a positive feedback loop. Blocking NF-kappa B signaling abolished the oncogenic roles of LINC01578 in colon cancer. Furthermore, the expression levels of LINC01578, NFKBIB, and YY1 were correlated in clinical tissues. Collectively, this study demonstrated that LINC01578 promoted colon cancer metastasis via forming a positive feedback loop with NF-kappa B/YY1 and suggested that LINC01578 represents a potential prognostic biomarker and therapeutic target for colon cancer metastasis.